Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-25

Clinical Trial Update: Mouthwash With Chlorhexidine 0.12%/Ethyl Alcohol 7% Compared to Ethyl Alcohol 7% [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing chlorhexidine gluconate mouthwash (0.12%) with 7% ethyl alcohol to ethyl alcohol alone (7%) for neutropenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorhexidine gluconate mouthwash 0.12% (chlorhexidine gluconate)
  • Ethyl alcohol mouthwash 7% (ethyl alcohol)

Snippet

Sponsor: Hospital Regional de Alta Especialidad del Bajio | Conditions: Neutropenia | Phase 3 | Status: COMPLETED